DELIVER at the AHA

The DELIVER team was proud to present 6 new papers at the American Heart Association scientific sessions in Chicago this week. The following analyses were presented:

• First and Repeat Episodes of Worsening Heart Failure in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction: An Analysis of DELIVER presented by Pardeep Jhund

• Influence of dapagliflozin on quality of life in patients with heart failure with mildly reduced or preserved ejection fraction presented by Mikhail Kosiborod

• Sex Differences in Characteristics, Outcomes and Treatment Response with Dapagliflozin across the Range of Ejection Fraction in Patients with Heart Failure presented by Wendy Wang

• Dapagliflozin in Black and White Patients With Heart Failure presented by Jawad Butt

• Impact of Coronavirus Disease-2019 in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction presented by Ankeet Bhatt

• Dapagliflozin in patients with HFmrEF/HFpEF treated with an MRA or sacubitril/valsartan presented by Mingming Yang